Page 1846 - Cote clinical veterinary advisor dogs and cats 4th
P. 1846

Soft-Tissue Sarcoma   927




            Soft-Tissue Sarcoma                                                                    Client Education
                                                                                                          Sheet
  VetBooks.ir                                                                                                         Diseases and   Disorders

                                               •  Sarcomas in specific sites may present with
            BASIC INFORMATION
                                                physical exam findings related to the location    TREATMENT
           Definition                           of the tumor (e.g., abdominal pain, weight   Treatment Overview
           A group of common tumors arising from   loss, dehydration).            •  The goal of treatment for soft-tissue sarcomas
           various mesenchymal tissues, they are classified                         in dogs or cats is complete eradication of the
           together because of similar biological behavior   Etiology and Pathophysiology  primary tumor.
           and  treatment.  They  include  fibrosarcoma,   •  Soft-tissue  sarcomas  arise  spontaneously   •  In  cases  where  the  tumor  cannot  be
           hemangiopericytoma, malignant fibrous histio-  in  dogs  and  cats.  Genetic  and  environ-  eliminated entirely, the goal of treatment
           cytoma, nerve sheath tumor, neurofibrosarcoma,   mental factors may be involved in tumor   is prevention or delayed development of
           malignant  schwannoma,  leiomyosarcoma,   development, but these factors are poorly   metastases.
           rhabdomyosarcoma, liposarcoma, myxosarcoma,   understood.              •  Palliative  treatment  options,  such  as  pal-
           lymphangiosarcoma, and synovial cell sarcoma.   •  Specific lesions and overt clinical manifesta-  liative irradiation, may help control pain
           Although it is also a mesenchymal tumor   tions caused by soft-tissue sarcomas depend   or discomfort in patients with advanced
           arising from soft tissue, hemangiosarcoma is   on location of the primary tumor and inva-  tumors or when definitive treatment is not an
           often excluded from this group because of its   sion into and destruction of surrounding   option.
           aggressive biological behavior.      normal structures.                •  Consultation with an oncologist is recom-
                                                                                    mended.
           Synonym                              DIAGNOSIS
           Soft-part sarcomas                                                     Acute General Treatment
                                               Diagnostic Overview                Surgery:
           Epidemiology                        Definitive diagnosis can be confirmed only   •  Commonly, these tumors appear encapsulated
           SPECIES, AGE, SEX                   by histopathologic exam, although additional   at surgery. This can be misleading because
           •  Common in middle-aged to older dogs  tests such as diagnostic imaging are useful for   the capsule is usually a pseudocapsule made
           •  Soft-tissue  sarcomas  at  sites  other  than   defining the extent of the tumor. An aggressive   of compressed tumor cells, and viable
             injection sites are less common in cats.  first surgery is more likely to result in tumor   tumor cells are often present beyond the
                                               control. An incisional biopsy should be per-  pseudocapsule.
           GENETICS, BREED PREDISPOSITION      formed first to establish the diagnosis. After the   •  Surgery  should  be  aimed  at  an  aggressive
           They tend to occur more commonly in larger   tumor type is confirmed, definitive treatment   resection of the mass with as wide a margin
           breeds, but direct inheritance of these tumors   can be planned and performed correctly. A   of normal tissue as possible from around the
           has not been reported.              global approach to diagnosis and management   tumor. When this is not possible because of
                                               is outlined on p. 1451.              the size and/or location of the tumor, radia-
           RISK FACTORS                                                             tion therapy may be indicated in addition
           •  Certain sarcomas have been associated with   Differential Diagnosis   to surgery.
             metal implants, previous exposure to ion-  •  Mast cell tumors       Radiation therapy:
             izing radiation, implanted microchips, and   •  Other skin and subcutaneous tumors: lipoma,   •  May be used before surgery when the tumor
             parasites (Spirocerca lupi).       histiocytoma, others                is not easily resectable due to location or size.
           •  Sarcomas at injection sites are well described   •  Other masses: abscess, granuloma  In cases where surgery is attempted first but
             in cats (p. 550) but rare in dogs.                                     resection is incomplete based on histologic
                                               Initial Database                     evaluation, patients should be treated with
           ASSOCIATED DISORDERS                •  Fine-needle aspiration and cytologic exam   radiation therapy after surgery.
           Hypoglycemia and diabetes insipidus have been   may help identify the type of soft-tissue   •  Hypofractionated radiation (fewer treatments
           reported as uncommon paraneoplastic syn-  sarcoma or differentiate it from other tumor   with larger doses per treatment) may be
           dromes in dogs with intestinal leiomyosarcoma.  types.                   beneficial in controlling soft-tissue sarcomas
                                               •  Thoracic radiographs to rule out pulmonary   with or without surgery.
           Clinical Presentation                metastases                        Chemotherapy:
           HISTORY, CHIEF COMPLAINT            •  Radiographs  of  the  affected  area  may   •  May be indicated for patients with high-grade
           •  Most  animals  present  for  a  progressively   (rarely)  reveal  involvement  of  underlying     tumors, tumors in certain locations, certain
             enlarging mass noticed by the owner.  bone.                            tumor types, and in patients that develop
           •  Animals with sarcoma in certain locations   •  Fine-needle  aspiration  of  draining  lymph   metastatic disease
             are presented because of clinical signs related   nodes to help rule out metastasis  •  Chemotherapy drugs that have been used
             to the location of the tumor. Dogs with                                for soft-tissue sarcoma include doxorubicin,
             oral tumors often present due to halitosis,   Advanced or Confirmatory Testing  mitoxantrone, platinum drugs, ifosfamide,
             difficulty eating or prehending food, oral   •  CT or MRI may be necessary to delineate   and combinations.
             bleeding, or a visible oral mass. Dogs with   the local extent of the tumor and plan for   •  Metronomic chemotherapy, using daily low
             intestinal sarcomas often are presented   surgery or radiation therapy.  doses of chemotherapy, has been shown to
             because of signs related to an intestinal mass,   •  Diagnosis is based on histopathologic evalu-  slow the time to recurrence for incompletely
             including vomiting and diarrhea.   ation of tissue. Occasionally, special stains   excised canine soft-tissue sarcomas. It may
                                                are necessary to differentiate various types   be considered as an alternative to irradiation
           PHYSICAL EXAM FINDINGS               of soft-tissue sarcomas, especially poorly   for some cases.
           •  Visible or palpable mass. Regional lymph-  differentiated tumors.   •  Marginal tumor excision with intralesional
             adenopathy may be present secondary to   •  Histopathologic grade of the tumor is neces-  chemotherapy beads can result in long-term
             inflammation caused by the tumor or (rarely)   sary for determining prognosis and treatment   control and may be considered as an alterna-
             lymph node metastasis.             of most soft-tissue sarcomas.       tive to radiation therapy for some cases.

                                                      www.ExpertConsult.com
   1841   1842   1843   1844   1845   1846   1847   1848   1849   1850   1851